NCT07107139 Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effects
| NCT ID | NCT07107139 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Roswell Park Cancer Institute |
| Condition | Smokeless Tobacco |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-05-11 |
| Primary Completion | 2027-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2026-05-11 with a primary completion date of 2027-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study seeks to measure the effects of smokeless tobacco product risk messages on sensory experiences and future intentions to use.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 21 years of age * Residing in 8 counties of Western NY (Erie, Niagara, Cattaraugus, Chautauqua, Allegheny, Livingston, Genesee, Orleans, Wyoming) * Smoke cigarettes every day, at least 5 cigarettes per day, for at least 1 year * Open to trying a non-combusted oral tobacco product * Have the ability to read, write, and communicate in English * Have successfully completed our preliminary Auction study I-4008824 with a bid for Copenhagen and/or General Snus \> $0 * Willing to abstain smoking 8-10 hours prior to each laboratory session and complete breath CO test for verification (\<8ppm) * Female participants must be amenable to taking a pregnancy test (urine) prior to beginning study procedures. * Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure. Exclusion Criteria: * Age ≥ 21 years of age * Residing in 8 counties of Western NY (Erie, Niagara, Cattaraugus, Chautauqua, Allegheny, Livingston, Genesee, Orleans, Wyoming) * Smoke cigarettes every day, at least 5 cigarettes per day, for at least 1 year * Open to trying a non-combusted oral tobacco product * Have the ability to read, write, and communicate in English * Have successfully completed our preliminary Auction study I-4008824 with a bid for Copenhagen and/or General Snus \> $0 * Willing to abstain smoking 8-10 hours prior to each laboratory session and complete breath CO test for verification (\<8ppm) . * Female participants must be amenable to taking a pregnancy test (urine) prior to beginning study procedures. * Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07107139 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, studying Smokeless Tobacco. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07107139 currently recruiting?
Yes, NCT07107139 is actively recruiting participants. Contact the research team at askrpci@roswellpark.org for enrollment information.
Where is the NCT07107139 trial being conducted?
This trial is being conducted at Buffalo, United States.
Who is sponsoring the NCT07107139 clinical trial?
NCT07107139 is sponsored by Roswell Park Cancer Institute. The trial plans to enroll 50 participants.